Kazuyuki Numakura

Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer

Shigeru Satoh, Takeshi Yuasa, Takashi Obara, 2012, International Journal of Clinical Oncology.

Comparison of Pharmacokinetics and Pharmacogenetics of Once- and Twice-Daily Tacrolimus in the Early Stage After Renal Transplantation

Shigeru Satoh, T. Habuchi, N. Tsuchiya, 2012, Transplantation.

Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome.

Shigeru Satoh, Takashi Obara, Yohei Horikawa, 2011, Carcinogenesis.